Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1865 of 6351
-
New hope for kids with tough leukemia: drug combo enters human testing
Disease control Recruiting nowThis is a Phase 1, open label, multicenter, dose finding study with dose expansion intended to evaluate the safety and tolerability of talazoparib in combination with conventional chemotherapy. Preliminary estimates of efficacy will be obtain through a dose expansion cohort recei…
Phase 1 • Sponsor: Norman J. Lacayo • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Hunter syndrome drug JR-141 tested for Long-Term safety
Disease control By invitation onlyAn extension of Global Phase III open-label, multicenter designed to evaluate the Long-term safety and efficacy of study drug for the treatment of the MPS II.
Phase 3 • Sponsor: JCR Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Can light therapy boost eczema treatment? new trial tests UVB plus creams
Disease control OngoingThe goal of this randomized controlled trial is to study the (cost)effectiveness of NB-UVB phototherapy in patients with atopic eczema/atopic dermatitis. Half of the participants will undergo a course of NB-UVB phototherapy of 8-16 weeks and apply optimal topical therapy (OTT) f…
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New study probes Obesity's role in pancreatic cancer among minorities
Knowledge-focused Recruiting nowThis study will evaluate obesity-mediated mechanisms of pancreatic carcinogenesis in minority populations.
Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
New combo therapy aims to help PBC patients who Don't respond to standard treatment
Disease control Recruiting nowCurrent treatment guidelines recommend ursodeoxycholic acid (UDCA) as the first-line treatment for new-diagnosed primary biliary cholangitis (PBC) patients. However, up to 40% patients are insensitive to UDCA monotherapy, and evaluation of UDCA response at 12 months may result in…
Phase 3 • Sponsor: Xijing Hospital of Digestive Diseases • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New pill takes aim at Hard-to-Treat myeloma
Disease control Recruiting nowA Phase I study to evaluate the safety of a novel, orally available, selective, and potent small molecule inhibitor of the histone lysine methyl transferase MMSET (also known as NSD2/WHSC1) to prevent the dimethylation of H3K36 in adult patients with relapsed or refractory multip…
Phase 1 • Sponsor: K36 Therapeutics, Inc. • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Massive flu drug showdown: 3,000 volunteers needed to find best antiviral
Disease control Recruiting nowThis trial will use a previously validated platform, to quantitatively assess antiviral effects in low-risk patients with high viral burdens and uncomplicated influenza, to determine in-vivo antiviral activity. In this randomised, open-label, controlled, group sequential, adaptiv…
Phase 2 • Sponsor: University of Oxford • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Gentler chemo for seniors with lung cancer: a new hope?
Disease control Recruiting nowThis is an open-label, non-randomized, single-center, phase II study to evaluate the efficacy, toxicity and, tolerability of pre-specified dose attenuated chemotherapy regimens in lung cancer patients with comorbidities.
Phase 2 • Sponsor: Fox Chase Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Could efgartigimod tame lupus nephritis? early trial hints at hope
Disease control CompletedThe purpose of the study is to evaluate the efficacy and safety of efgartigimod IV in Chinese patients with active lupus nephritis (LN). The study comprises an approximate 4-week screening period, a 24-week treatment period, and an 8-week follow- up period.
Phase 2 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
One dose or two? study aims to ease pain for people on methadone
Symptom relief Recruiting nowThis study will evaluate whether once versus twice daily dosing of methadone will be an effective method for managing comorbid pain and opioid use disorder.
Phase 2/3 • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Brain zapping tailored to you: new study targets depression and anxiety
Symptom relief Recruiting nowThe research study is being conducted to study brain patterns of negative emotion and develop personalized brain stimulation protocols to disrupt these patterns with transcranial magnetic stimulation (TMS). First, the investigators will use functional Magnetic Resonance Imaging (…
Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
New precision tool aims to improve liver cancer ablation
Disease control Recruiting nowTo achieve adequate tumor treatment coverage with sufficient minimal ablation margins, several steps are required: firstly, it is critical to define tumor boundaries and extent on intra-procedural CT image; secondly, accurate planning, targeting, and confirmation of ablation prob…
Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New hope for tough lymphomas: GNC-038 trial underway
Disease control OngoingTo explore the safety and efficacy of GNC-038 in relapsed or refractory NK/T cell lymphoma, vascular immunomother T cell lymphoma, and other relapsed or refractory NHL, and to determine MTD, MAD, DLT, and RP2D of GNC-038, as well as its pharmacokinetic characteristics and immunog…
Phase 1/2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New drug navenibart aims to tame hereditary swelling attacks
Disease control CompletedThe goal of this clinical trial is to test the drug navenibart in participants with hereditary angioedema (HAE). One group of participants will get 1 dose of navenibart, and 2 other groups will get 2 doses of navenibart. Researchers will study the effects of navenibart in partici…
Phase 1/2 • Sponsor: Astria Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Could a surgeon's mental health impact your surgery outcome?
Knowledge-focused CompletedThe objective of this prospective cohort study is to explore the association between the development of post-traumatic stress disorder (PTSD) in surgeons and anesthesiologists and postoperative prognosis in surgical patients they care for during the COVID-19 pandemic. There are 2…
Sponsor: Xijing Hospital • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
Can a battery keep ventilators running during ambulance transport?
Knowledge-focused CompletedThe HERMES Phase I-II study was a two-phase observational investigation designed to characterize contemporary practices and safety-related challenges associated with the transport of patients requiring advanced respiratory support and to assess the operational feasibility of port…
Sponsor: Medipol University • Aim: Knowledge-focused
Last updated Sep 10, 2026 07:00 UTC
-
Caffeine may clear Post-Surgery brain fog in seniors
Symptom relief CompletedThe objective of this study is to test the effects of caffeine on neurocognitive and clinical recovery after major surgery. Specifically, this trial tests the primary hypothesis that caffeine will reduce the incidence of postoperative delirium.
Phase 2 • Sponsor: University of Michigan • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
New triple treatment offers hope for chronic back pain after surgery
Symptom relief CompletedThis interventional study evaluates a "triple therapy" approach-combining percutaneous spinal fixation, facet radiofrequency ablation, and epidural steroid/hyaluronidase injection-for patients with Failed Back Surgery Syndrome (FBSS). The study compares this combined strategy aga…
Phase 2 • Sponsor: Benha University • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Brain zaps + arm training: new hope for stroke survivors?
Symptom relief CompletedThe goal of this clinical trials is to investigate the effectiveness of online repetitive transcranial magnetic stimulation (rTMS) in enhancing upper limb motor rehabilitation during the subacute and chronic phase of stroke. It will also learn about the safety of online rTMS inte…
Sponsor: Ruijin Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
Balloon vs stent: which works better for elderly heart patients?
Disease control CompletedThe goal of this clinical trial was to compare the effectiveness of drug balloons versus drug-coated stents in calcified lesions in elderly coronary artery disease. The main question it aims to answer is whether the application of DCB is non-inferior to DES for in situ large vess…
Sponsor: Henan Institute of Cardiovascular Epidemiology • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC